UMass Amherst researchers have developed a groundbreaking nanoparticle-based cancer vaccine that prevented melanoma, ...

In 2006 immunologist and 2025 Nobel prize winner Shimon Sakaguchi co-wrote an article in Scientific American that now feels ...

A nanoparticle-based vaccine prevented melanoma, pancreatic, and breast cancers in mice, keeping up to 88% tumor-free and ...

A special group of immune cells known as regulatory T cells, or Tregs for short, became an overnight sensation when a trio of ...

Nobel laureate Shimon Sakaguchi reflects on the role of regulatory T cells in peripheral immune tolerance and how the cells ...

Researchers have discovered giant DNA structures in oral bacteria, and data hint they could influence the function of your ...

Many advanced cancers develop resistance to treatment and become highly aggressive, often leaving patients with limited ...

In-vitro studies confirm that the Company’s novel Smart mRNA could drastically reduce off-target liver toxicity, a major issue affecting many cancer drugs ...

New research reveals that chemotherapy may cause “chemo brain” by damaging the brain’s lymphatic system — the network responsible for clearing waste and supporting immune function.

Chief of Medical Oncology and Hematology at Mercy Medical Center Dr. David Riseberg joins Jennifer Franciotti to discuss emerging therapies to treat aggressive forms of breast cancer.

Presentation will cover two-year clinical efficacy, immunogenicity and safety dataData will be presented at an oral session on October 17, 2025, followed by a webinar on October 22, 2025, providing ...